Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Gadodiamide vs Gadoteric Acid in Renal Insufficiency
NCT04776187Phase 4Unknown
- Sponsor
- Lishui City Central Hospital
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoterate meglumine, sponsored by Lishui City Central Hospital. Status: unknown.
02
Drugs
gadoterate meglumine
Beyond the preview
Go deeper on NCT04776187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776187.